Evidence map›Paper›PMID 34713801›Full record

ArticleeLife2021

Paths and pathways that generate cell-type heterogeneity and developmental progression in hematopoiesis.

Juliet R Girard, Lauren M Goins, Dung M Vuu, Mark S Sharpley, Carrie M Spratford, Shreya R Mantri, Utpal Banerjee

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Niche-derived exosomes controlFrontiers in immunology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. TheeLife · 2025
    Article
  15. ThebioRxiv : the preprint server for biology · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Formation of recurring transient CaProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Juliet R Girard *Department of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, United States.ORCID 0000-0001-8274-2136
Lauren M Goins *Department of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, United States.
Dung M Vuu *Department of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, United States.
Mark S SharpleyDepartment of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, United States.
Carrie M SpratfordDepartment of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, United States.
Shreya R MantriDepartment of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, United States.
Utpal BanerjeeDepartment of Molecular, Cell and Developmental Biology, University of California, Los Angeles, Los Angeles, United States.ORCID 0000-0001-6247-0284
University of California, Los Angeles · US

Funding

TUMOR CELL SURFACES AND CHROMOSOMEST32CA009056 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Gay M Crooks, David A. Nathanson · 1985 to 2026
$10.5M
Genomic and Genetic Dissection of Hematopoietic Development in DrosophilaR01HL067395 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SIEKHAUS, DARIA E · 2001 to 2025
$9.0M
Vascular Biology Training GrantT32HL069766 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LUSIS, ALDONS JAKE · 2002 to 2022
$7.4M
UPLIFT: UCLA Postdocs' Longitudinal Investment in Faculty TrainingK12GM106996 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CAREY, MICHAEL F, VILLANUEVA, CLAUDIO J · 2016 to 2025
$7.1M
Metabolic and signaling control of tumorformation in drosophilaR01CA217608 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BANERJEE, UTPAL · 2017 to 2021
$1.8M
NCI NIH HHS R01 CA217608NCI NIH HHS T32 CA009056NHLBI NIH HHS R01 HL067395NHLBI NIH HHS T32 HL069766NHLBI NIH HHS T32-HL863458NIGMS NIH HHS K12 GM106996
6 · The paper itself

Abstract

Mechanistic studies of

Indexed as

HematopoiesisAnimalsDNA-Binding ProteinsDrosophila melanogasterDrosophila ProteinsFemaleHemocytesHemolymphJuvenile HormonesLarvaMaleDNA-Binding ProteinsDrosophila ProteinsJuvenile Hormonesnumb protein, DrosophilaSima protein, Drosophilablood progenitorscrystal cellsdevelopmental biologyD. melanogastergeneticsgenomicshematopoiesisintermediate progenitorslymph glandstem cells

Identifiers

PMID34713801
PMCPMC8610493
OpenAlexW3209235406

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.